High frequency of LMAN1 abnormalities in colorectal tumors with microsatellite instability

Cancer Research

Volumn 69, Issue 1, 2009, Pages 292-299

  Roeckel, Nina ^a   Woerner, Stefan M ^a   Kloor, Matthias ^a   Yuan, Yan Ping ^b   Patsos, Georgios ^a   Gromes, Roland ^a   Kopitz, Juergen ^a   Gebert, Johannes ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ANTIANGIOGENIC ACTIVITY; ARTICLE; B4GALNT4 GENE; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; COLORECTAL TUMOR; ENDOPLASMIC RETICULUM; EPITOPE MAPPING; ERGIC53 GENE; FRAMESHIFT MUTATION; GENE; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE MUTATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LMAN1 GENE; MICROSATELLITE INSTABILITY; ONCOGENE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN SYNTHESIS; XYLT2 GENE;

ALPHA 1-ANTITRYPSIN; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FRAMESHIFT MUTATION; GENE EXPRESSION; HUMANS; MANNOSE-BINDING LECTINS; MEMBRANE PROTEINS; MICROSATELLITE INSTABILITY; RNA, MESSENGER;

EID: 58249110386     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3314     Document Type: Article

References (41)

1. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993;363:558-61.
2. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-9.
3. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
4. Kane MF, Loda M, Gaida GM, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 1997;57:808-11.
5. Kloor M, von Knebel Doeberitz M, Gebert JF. Molecular testing for microsatellite instability and its value in tumor characterization. Expert Rev Mol Diagn 2005;5:599-611.
6. Grady WM, Rajput A, Myeroff L, et al. Mutation of the type II transforming growth factor-β receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res 1998;58:3101-4.
7. Ionov Y, Yamamoto H, Krajewski S, Reed JC, Perucho M. Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution. Proc Natl Acad Sci U S A 2000;97:10872-7.
8. Hempen PM, Zhang L, Bansal RK, et al. Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers. Cancer Res 2003;63:994-9.
9. Woerner SM, Benner A, Sutter C, et al. Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative Real Common Target genes. Oncogene 2003;22:2226-35.
10. Gabius H-J. The Sugar Code. Fundamentals of Glycosciences. Weinheim (Germany): VHC Viley; 2008.
11. Zhao Y, Sato Y, Isaji T, et al. Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J 2008;275:1939-48.
12. Helenius A, Aebi M. Intracellular functions of N-linked glycans. Science 2001;291:2364-9.
13. Schrag JD, Procopio DO, Cygler M, Thomas DY, Bergeron JJ. Lectin control of protein folding and sorting in the secretory pathway. Trends Biochem Sci 2003;28:49-57.
14. Yang JM, Byrd JC, Siddiki BB, et al. Alterations of O-glycan biosynthesis in human colon cancer tissues. Glycobiology 1994;4:873-84.
15. Kellokumpu S, Sormunen R, Kellokumpu I. Abnormal glycosylation and altered Golgi structure in colorectal cancer: dependence on intra-Golgi pH. FEBS Lett 2002;516:217-24.
16. Brockhausen I. Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep 2006;7:599-604.
17. Vercoutter-Edouart AS, Slomianny MC, keyzer-Beseme O, Haeuw JF, Michalski JC. Glycoproteomics and glycomics investigation of membrane N-glycosylproteins from human colon carcinoma cells. Proteomics 2008;8:3236-56.
18. Kawamura YI, Toyota M, Kawashima R, et al. DNA hypermethylation contributes to incomplete synthesis of carbohydrate determinants in gastrointestinal cancer. Gastroenterology 2008;135:142-51.
19. Patsos G, Robbe-Masselot C, Klein A, et al. O-glycan regulation of apoptosis and proliferation in colorectal cancer cell lines. Biochem Soc Trans 2007;35:1372-4.
20. Iwai T, Kudo T, Kawamoto R, et al. Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. Proc Natl Acad Sci U S A 2005;102:4572-7.
21. Kim YS, Hwang SY, Kang HY, et al. Functional proteomics study reveals that N-Acetylglucosaminyl-transferase V reinforces the invasive/metastatic potential of colon cancer through aberrant glycosylation on tissue inhibitor of metalloproteinase-1. Mol Cell Proteomics 2008;7:1-14.
22. Ono M, Hakomori S. Glycosylation defining cancer cell motility and invasiveness. Glycoconj J 2004;20:71-8.
23. Woerner SM, Gebert J, Yuan YP, et al. Systematic identification of genes with coding microsatellites mutated in DNA mismatch repair-deficient cancer cells. Int J Cancer 2001;93:12-9.
24. Findeisen P, Kloor M, Merx S, et al. T25 repeat in the 3′ untranslated region of the CASP2 gene: a sensitive and specific marker for microsatellite instability in colorectal cancer. Cancer Res 2005;65:8072-8.
25. Woerner SM, Kloor M, Schwitalle Y, et al. The putative tumor suppressor AIM2 is frequently affected by different genetic alterations in microsatellite unstable colon cancers. Genes Chromosomes Cancer 2007;46:1080-9.
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
27. Nyfeler B, Reiterer V, Wendeler MW, et al. Identification of ERGIC-53 as an intracellular transport receptor of α1-antitrypsin. J Cell Biol 2008;180:705-12.
28. Huang H, Campbell SC, Nelius T, et al. α1-antitrypsin inhibits angiogenesis and tumor growth. Int J Cancer 2004;112:1042-8.
29. Stephens DJ, Pepperkok R. Illuminating the secretory pathway: When do we need vesicles? J Cell Sci 2001;114:1053-9.
30. Hauri HP, Kappeler F, Andersson H, Appenzeller C. ERGIC-53 and traffic in the secretory pathway. J Cell Sci 2000;113:587-96.
31. Hauri HP, Nufer O, Breuza L, Tekaya HB, Liang L. Lectins and protein traffic early in the secretory pathway. Biochem Soc Symp 2002;69:73-82.
32. Appenzeller C, Andersson H, Kappeler F, Hauri HP. The lectin ERGIC-53 is a cargo transport receptor for glycoproteins. Nat Cell Biol 1999;1:330-4.
33. Moussalli M, Pipe SW, Hauri HP, Nichols WC, Ginsburg D, Kaufman RJ. Mannose-dependent endoplasmic reticulum (ER)-Golgi intermediate compartment-53-mediated ER to Golgi trafficking of coagulation factors V and VIII. J Biol Chem 1999;274:32539-42.
34. Vollenweider F, Kappeler F, Itin C, Hauri HP. Mistargeting of the lectin ERGIC-53 to the endoplasmic reticulum of HeLa cells impairs the secretion of a lysosomal enzyme. J Cell Biol 1998;142:377-89.
35. You KT, Li LS, Kim NG, et al. Selective translational repression of truncated proteins from frameshift mutation-derived mRNAs in tumors. PLoS Biol 2007;5:e109.
36. Carlson JA, Rogers BB, Sifers RN, Hawkins HK, Finegold MJ, Woo SL. Multiple tissues express α 1-antitrypsin in transgenic mice and man. J Clin Invest 1988;82:26-36.
37. Geboes K, Rutgeerts P, Vantrappen G, Desmet VJ. Immunoreactivity of α-1-antitrypsin in the human colon. Hepatogastroenterology 1983;30:24-6.
38. Allgayer H, Babic R, Grutzner KU, et al. Tumor-associated proteases and inhibitors in gastric cancer: analysis of prognostic impact and individual risk protease patterns. Clin Exp Metastasis 1998;16:62-73.
39. Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 1999;106:574-82.
40. Campellone KG, Webb NJ, Znameroski EA, Welch MD. WHAMM is an Arp2/3 complex activator that binds microtubules and functions in ER to Golgi transport. Cell 2008;134:148-61.
41. Nyfeler B, Zhang B, Ginsburg D, Kaufman RJ, Hauri HP. Cargo selectivity of the ERGIC-53/MCFD2 transport receptor complex. Traffic 2006;7:1473-81.